Press Releases

The Assistance Fund Opens New Program for Chronic Inflammatory Demyelinating Polyneuropathy


Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Chronic Inflammatory Demyelinating Polyneuropathy

ORLANDO, Fla., June 14, 2022 —The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new financial assistance program for people living with chronic inflammatory demyelinating polyneuropathy (CIDP). The program is designed to help eligible individuals pay for their out-of-pocket medical expenses related to CIDP, such as copays, health insurance premiums, therapy administration costs, and treatment-related ground travel costs.

“Individuals and families living with CIDP will likely spend multiple years on much needed treatment to improve their quality of life and maintain their condition,” said Lisa Butler, Executive Director of GBS/CIDP Foundation International. “We are so grateful for this new program with The Assistance Fund and look forward to better adherence to treatment, some financial relief, and a subsequently improved quality of life.”

Chronic inflammatory demyelinating polyneuropathy is a neurological disorder characterized by progressive weakness and impaired sensory function in the legs and arms.¹ The disorder, which is sometimes called chronic relapsing polyneuropathy, is caused by damage to the myelin sheath of the peripheral nerves. “For many patients living with CIDP, timely access to treatment is the difference between walking and a wheelchair,” said Mark P. McGreevy, President and CEO of The Assistance Fund. “With the tremendous support of our donors, our new Chronic Inflammatory Demyelinating Polyneuropathy Financial Assistance Program will ensure hundreds of people living with this challenging disease get the care they need.”

To learn more or determine eligibility for financial support, visit or call (855) 530-2242 to speak with a Patient Advocate.

A list of all the disease programs available from The Assistance Fund can be found on the website

About The Assistance Fund

The Assistance Fund (TAF) is an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles, and other health-related expenses. The Assistance Fund currently manages nearly 80 disease programs, each of which covers all the FDA-approved medications that treat a specific disease named in the disease program. Since its founding in 2009, TAF has helped more than 160,000 children and adults access the treatment they need to stay healthy or manage a life-threatening, chronic, or rare disease. To learn more about The Assistance Fund, or for information on how to donate, please visit

Media Contact
Margaret Figley
Senior Director of Communications

¹ National Institute of Neurological Disorders and Stroke, “Chronic Inflammatory Demyelinating Polyneuropathy (CIDP),”, accessed June 2022.

Share This
Categories: Press Releases